Commit To Buy Regeneron Pharmaceuticals At $300, Earn 6.7% Using Options
September 26, 2016 at 11:43 AM EDT
Investors eyeing a purchase of Regeneron Pharmaceuticals, Inc. (REGN) stock, but cautious about paying the going market price of $402.42/share, might benefit from considering selling puts among the alternative strategies at their disposal..